Hong Kong Medical Equipment Stock News

The Sky Light Holdings Limited ( HKG:3882 ) share price has fared very poorly over the last month, falling by a...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider...

TATA Health International Holdings Limited ( HKG:1255 ) shares have had a really impressive month, gaining 28% after a...

Unfortunately for some shareholders, the Inspur Digital Enterprise Technology Limited ( HKG:596 ) share price has dived...

Kingwell Group Limited ( HKG:1195 ) shares have had a really impressive month, gaining 32% after a shaky period...

Daohe Global Group Limited ( HKG:915 ) shareholders would be excited to see that the share price has had a great month...

Daohe Global Group Limited ( HKG:915 ) shareholders would be excited to see that the share price has had a great month...

Despite an already strong run, Huabao International Holdings Limited ( HKG:336 ) shares have been powering on, with a...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

eSun Holdings Limited ( HKG:571 ) shares have had a really impressive month, gaining 26% after a shaky period...

Key Insights TravelSky Technology's significant private companies ownership suggests that the key decisions are...

Key Insights Significant control over China Resources Power Holdings by private companies implies that the general...

Tencent Holdings (SEHK:700) received regulatory approval to purchase Nvidia’s H200 artificial intelligence chips. The company also launched Hong Kong’s first palm verification check in system for healthcare in partnership with Bupa. Tencent’s latest moves plug directly into two big themes investors are watching for the company: AI infrastructure and real world use of its technology. With the share price at HK$606.0 and a 1 year return of 52.4%, the stock has recently delivered strong gains,...

Prada, listed as SEHK:1913, is putting harmonised sustainability data frameworks at the centre of its reporting approach. Lorenzo Bertelli, Chief Marketing Officer and Head of CSR, recently outlined the group’s focus on standardised environmental data collection. The move aims to align Prada’s sustainability metrics with the expectations of investors, consumers, and regulators. For investors watching Prada at a current share price of HK$40.04, the renewed attention to consistent...

In the past few days, JAMA Dermatology published Phase II data showing InnoCare Pharma’s TYK2 inhibitor soficitinib delivered encouraging efficacy and a favorable safety profile in patients with moderate-to-severe atopic dermatitis, while the company also completed enrollment of 579 patients for its Phase III trial in the same indication. This combination of peer-reviewed validation and late-stage trial readiness positions soficitinib as a potentially important entrant in the competitive...

Hang Lung Properties has reported its full-year 2025 results, with sales of HK$9,950 million and net income of HK$1,806 million, and the board has recommended a final cash dividend of HK$0.40 per share for the year ending December 31, 2026, payable on June 15, 2026. The proposed final dividend, coming alongside lower sales and earnings compared with the prior year, highlights management’s commitment to cash returns even as profitability softened. We’ll now look at how the earnings decline...

In past guidance for 2025, Air China Limited said it expects to post a net loss of about RMB 1.30 billion to RMB 1.90 billion, with an even larger loss of roughly RMB 1.90 billion to RMB 2.70 billion after excluding non-recurring items. This outlook highlights how underlying operations, once one-off gains and losses are stripped out, could weigh more heavily on Air China’s financial performance. Next, we’ll examine how this projected 2025 loss, particularly after excluding non-recurring...

Aluminum Corporation of China (SEHK:2600) reported a reshuffle in its company secretary roles, with the previous company secretary resigning. The board appointed two joint company secretaries: long serving executive Ms. Zhu Dan and corporate governance specialist Mr. Chow Tsz Ho. The move brings together internal operational experience and external compliance expertise in the core governance function. For investors watching Aluminum Corporation of China at HK$13.85, this governance change...

East Buy Holding Limited recently reported half-year results for the period ended November 30, 2025, with sales of CNY 2,311.63 million and net income of CNY 238.97 million, reversing a net loss in the same period a year earlier. The move from a basic loss per share of CNY 0.09 to basic earnings per share of CNY 0.23 highlights a meaningful operational turnaround and improved profitability from continuing operations. We will now examine how this swing back to profitability shapes East Buy...

If you are wondering whether CK Hutchison Holdings is attractively priced right now or if the recent excitement has already been baked into the share price, this article walks you through that question step by step. The stock recently closed at HK$63.25, with returns of 0.7% over 7 days, 19.5% over 30 days, 17.1% year to date, 69.3% over 1 year, 51.7% over 3 years, and 54.6% over 5 years. This naturally raises questions about how much value is still on the table. These moves are set against...

Huishang Bank (SEHK:3698) has proposed an interim dividend of CN¥1.87 per 10 shares for the six months to 30 June 2025, subject to shareholder approval scheduled for 2 February 2026. See our latest analysis for Huishang Bank. At a share price of HK$3.45, Huishang Bank has seen a 7.81% 30 day share price return and a 48.60% 1 year total shareholder return. This suggests recent momentum has been positive despite a small 1 day pullback, with the proposed interim dividend adding another focal...

AstraZeneca recently announced a new collaboration with CSPC Pharmaceutical Group to advance eight next-generation obesity and type 2 diabetes therapies, anchored by CSPC’s AI-driven peptide discovery and once-monthly LiquidGel injection platform, with AstraZeneca receiving worldwide rights outside China to CSPC’s once-monthly injectable weight management portfolio. The agreement includes an upfront payment of US$1.20 billion and up to US$3.50 billion in potential development and regulatory...

Hong Kong Exchanges and Clearing Limited recently issued earnings guidance for the full year 2025, forecasting net profit attributable to shareholders between RMB 147.99 million and RMB 180.17 million, with profit after excluding non-recurring items expected between RMB 29.19 million and RMB 39.50 million. This guidance points to a significant reduction in prior losses and highlights how non-recurring items still play a meaningful role in the company’s reported profitability. We will now...

BYD is accelerating its global expansion, reassessing its India plans in response to import rules and rising local EV demand. In Mexico, the company is reacting to higher tariffs on Chinese manufacturers with regional production and tighter inventory planning. BYD is investing in Vietnam through a new battery joint venture aimed at supporting local supply and vehicle manufacturing capabilities. Across Europe, BYD reports that its EV sales are outpacing petrol vehicles, reflecting gains...